Simendan

troponin C1, slow skeletal and cardiac type ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30489437 Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper. 2019 Jan 1
2 31730560 Potential of the Cardiovascular Drug Levosimendan in the Management of Amyotrophic Lateral Sclerosis: An Overview of a Working Hypothesis. 2019 Nov 1
3 29558109 Reversible Covalent Reaction of Levosimendan with Cardiac Troponin C in Vitro and in Situ. 2018 Apr 17 1
4 27673371 Reversible Covalent Binding to Cardiac Troponin C by the Ca2+-Sensitizer Levosimendan. 2016 Nov 1 8
5 25949787 Effect of levosimendan on the contractility of muscle fibers from nemaline myopathy patients with mutations in the nebulin gene. 2015 1
6 18570382 Defining the binding site of levosimendan and its analogues in a regulatory cardiac troponin C-troponin I complex. 2008 Jul 15 1
7 16181825 Pharmacology of new agents for acute heart failure syndromes. 2005 Sep 19 1
8 15646030 The contractile apparatus as a target for drugs against heart failure: interaction of levosimendan, a calcium sensitiser, with cardiac troponin c. 2004 Nov 4
9 12967628 Interaction of levosimendan with cardiac troponin C in the presence of cardiac troponin I peptides. 2003 Sep 1
10 11113122 Binding of levosimendan, a calcium sensitizer, to cardiac troponin C. 2001 Mar 23 7
11 10731446 Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: structure-response and binding analysis with analogs of levosimendan. 2000 Mar 4
12 10446160 Drug binding to cardiac troponin C. 1999 Aug 20 3
13 9876999 Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals. 1998 Dec 1
14 8523447 Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. 1995 Sep 7
15 7961805 Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study. 1994 Nov 18 9